Globus Medical, Inc., the largest privately held spinal implant manufacturer in the world, announced the launch of MicroFuse ST Granules, a unique resorbable polymer bone void filler optimized for both strength and porosity. MicroFuse technology utilizes proprietary combinations of poly (lactic acid) and poly (lactide-co-glycolide) polymers manufactured with a patented microsphere process to deliver up to twelve times the strength and twice the ideal porosity ratio of competing synthetic bone void fillers.

MicroFuse’s strength is derived from its unique three-dimensional structure which translates into better intra-operating handling characteristics. Due to its bonded sphere structure, MicroFuse is less likely to break apart while mixing with bone graft and during impaction at the bone defect site. MicroFuse’s structure is also designed to maximize the amount of pores in the optimal range for bone formation.

MicroFuse technology represents a unique entry into the synthetic bone substitute market. With an optimal combination of strength and porosity, MicroFuse is specifically engineered to resorb and be fully replaced by bone,” said Mark Borden, Ph.D., Director of Biomaterials, Globus Medical, Inc. “From the choice of resorbable polymers to the size of the individual microspheres, developmental efforts were focused on providing the best possible environment for bone growth.”

About Globus Medical, Inc.

Globus Medical, Inc., is the largest privately held spinal implant manufacturer in the world and is based in Audubon, Pa. The company was founded in 2003 by an experienced team of spine professionals with a shared vision to create products that enable spine surgeons to promote healing in patients with spinal disorders.

SOURCE Globus Medical, Inc.